1. Home
  2. NOTV vs LGCB Comparison

NOTV vs LGCB Comparison

Compare NOTV & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • LGCB
  • Stock Information
  • Founded
  • NOTV 1974
  • LGCB 2011
  • Country
  • NOTV United States
  • LGCB Japan
  • Employees
  • NOTV N/A
  • LGCB N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • LGCB
  • Sector
  • NOTV Health Care
  • LGCB
  • Exchange
  • NOTV Nasdaq
  • LGCB Nasdaq
  • Market Cap
  • NOTV 28.7M
  • LGCB 23.4M
  • IPO Year
  • NOTV 1997
  • LGCB 2023
  • Fundamental
  • Price
  • NOTV $0.87
  • LGCB $2.05
  • Analyst Decision
  • NOTV Strong Buy
  • LGCB
  • Analyst Count
  • NOTV 1
  • LGCB 0
  • Target Price
  • NOTV $5.00
  • LGCB N/A
  • AVG Volume (30 Days)
  • NOTV 1.6M
  • LGCB 58.7K
  • Earning Date
  • NOTV 12-03-2025
  • LGCB 07-03-2025
  • Dividend Yield
  • NOTV N/A
  • LGCB N/A
  • EPS Growth
  • NOTV N/A
  • LGCB N/A
  • EPS
  • NOTV N/A
  • LGCB N/A
  • Revenue
  • NOTV $505,299,000.00
  • LGCB $8,993,265.00
  • Revenue This Year
  • NOTV $5.64
  • LGCB N/A
  • Revenue Next Year
  • NOTV $5.16
  • LGCB N/A
  • P/E Ratio
  • NOTV N/A
  • LGCB N/A
  • Revenue Growth
  • NOTV 0.85
  • LGCB 5.80
  • 52 Week Low
  • NOTV $0.66
  • LGCB $1.22
  • 52 Week High
  • NOTV $6.48
  • LGCB $6.83
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 36.75
  • LGCB 54.46
  • Support Level
  • NOTV $0.77
  • LGCB $1.85
  • Resistance Level
  • NOTV $0.86
  • LGCB $2.09
  • Average True Range (ATR)
  • NOTV 0.13
  • LGCB 0.17
  • MACD
  • NOTV -0.01
  • LGCB 0.02
  • Stochastic Oscillator
  • NOTV 35.07
  • LGCB 64.62

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

Share on Social Networks: